RMTI · Rockwell Medical, Inc. · Executive Compensation
Market Cap
$27.97M
Shares
4.03M
Volume · Oct 26
11.12K
Avg daily vol (3M)
26.62K
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Mark Strobeck | Chief Executive Officer | $1,895,472 |
| Megan Timmins | Chief Legal Officer and Secretary | $978,159 |
| Jesse Neri | Chief Financial Officer | $828,809 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Mark Strobeck | Chief Executive Officer | $1,310,878 |
| Megan Timmins | Chief Legal Officer and Secretary | $749,889 |
| Jesse Neri | Chief Financial Officer | $539,458 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Mark Strobeck | Chief Executive Officer^(a)^ | $1,054,169 |
| Megan Timmins | Chief Legal Officer and Secretary | $660,288 |
| Marc Hoffman | Former Chief Medical Officer | $486,782 |
| Paul McGarry | Former Senior Vice President, Finance and CAO | $324,118 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Russell Ellison | Former Chief Executive Officer^(b)^ | $712,128 |
| Mark Strobeck | Chief Executive Officer^(a)^ | $711,762 |
| Megan Timmins | Chief Legal Officer and Secretary | $607,291 |
| Marc Hoffman | Former Chief Medical Officer | $586,612 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Raymond D. Pratt | Former Chief Development Officer(g) | $653,980 |
| Russell Ellison | Former Chief Executive Officer^(b)^ | $627,537 |
| Russell Skibsted | Former Chief Financial Officer^(b)^ | $598,923 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Russell Ellison | Chief Executive Officer(a) | $2,480,632 |
| Stuart Paul | Former Chief Executive Officer (a) | $1,000,946 |
| Russell Skibsted | Chief Financial Officer | $717,142 |
| Raymond D. Pratt | Former Chief Development Officer(g) | $581,106 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Ajay Gupta | Chief Scientific Officer | $736,730 |
| Stuart Paul | Former Chief Executive Officer (a) | $600,000 |
| Angus Smith | Chief Financial Officer | $485,750 |
Fiscal 2018
| Executive | Role | Total |
|---|---|---|
| Stuart Paul | Former Chief Executive Officer (a) | $7,483,803 |
| Angus Smith | Chief Financial Officer | $1,448,223 |
| Ajay Gupta | Chief Scientific Officer | $954,415 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Joseph H. Dawson | Nominating and Corporate Governance Committee | Appointed | 2025-11-18 |
| Joseph H. Dawson | Class II director | Appointed | 2025-11-18 |
| Andrea Heslin Smiley | Board of Directors | Resigned | 2025-11-18 |
| Heather Hunter | Senior Vice President and Chief Operating Officer | Appointed | 2025-09-29 |
| Jesse Neri | Senior Vice President and Chief Financial Officer | Appointed | 2024-12-12 |
| Joan Lau, PhD | Class II director | Appointed | 2023-10-17 |
| Paul McGarry | Senior Vice President, Finance and Chief Accounting Officer | Resigned | 2023-09-15 |
Leadership
- Mark Strobeck CEO, Board Member
- Mark Strobeck, Ph.D. CEO, Board Member
- Russell Ellison CEO, Board Member
- Russell H. Ellison, M.D., M.Sc. CEO
- Robert S. Radie Chairman
- Jesse Neri CFO
- Russell L. Skibsted CFO
- Heather Hunter COO
- Megan Timmins General Counsel
- Allen Nissenson Board Member
- Joan Lau Board Member
- Joan Lau, PhD Board Member
- John G. Cooper Board Member
- Joseph Dawson Board Member
- Joseph H. Dawson Board Member
- Mark H. Ravich Board Member
- Russell H. Ellison, MD, MSc Board Member